Biomatter Designs Company

Pioneering the technologies for generative protein design at the intersection of synthetic biology and AI.
Technology: Artificial Intelligence, Biotechnology, Pharmaceutical
Industry: Early Drug Development
Headquarters: Vilnius, Vilniaus Apskritis, Lithuania
Founded Date: 2018-01-01
Employees Number: 11-50
Funding Status: Seed
Investors Number: 2
Total Funding: 608000
Last Funding Date: 2021-01-11
Last Funding Type: Seed

Visit Website
hello@biomatterdesigns.com
Register and Claim Ownership